Open AccessCell therapy in the multimodality treatment of a patient with dilated cardiomyopathy. A case report
Author(s) -
S.A. Beliy,
V. Lukashenko,
Vladimir V. Komok,
Г. Г. Хубулава
Publication year - 2019
Publication title -
kardiologiâ
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.159
H-Index - 16
eISSN - 2412-5660
pISSN - 0022-9040
DOI - 10.18087/cardio.2555
Subject(s) - medicine , dilated cardiomyopathy , heart failure , cardiology , peripheral blood mononuclear cell , cardiomyopathy , ejection fraction , bone marrow , surgery , biochemistry , chemistry , in vitro
We present a 13-years follow-up results in patient with dilated cardiomyopathy. We performed intracoronary infusion of bone marrow mononuclear fraction in patient with 4th heart failure functional class in 2005. We observed an improvement in symptoms (patient had 1st functional class of heart failure) during 10-years follow-up. In 2015 due to clinical worsening we performed 2nd and 3rd bone marrow mononuclear cells infusion with 9-month interval. We observed a signifcant improvement in symptoms, EF and LV sizes. We continue the follow-up.